GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hai Phong Pharmaceutical JSC (HSTC:DPH) » Definitions » Debt-to-Asset

Hai Phong Pharmaceutical JSC (HSTC:DPH) Debt-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Hai Phong Pharmaceutical JSC Debt-to-Asset?

Hai Phong Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Hai Phong Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Hai Phong Pharmaceutical JSC's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₫0.00 Mil.


Hai Phong Pharmaceutical JSC Debt-to-Asset Historical Data

The historical data trend for Hai Phong Pharmaceutical JSC's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hai Phong Pharmaceutical JSC Debt-to-Asset Chart

Hai Phong Pharmaceutical JSC Annual Data
Trend
Debt-to-Asset

Hai Phong Pharmaceutical JSC Semi-Annual Data
Debt-to-Asset

Competitive Comparison of Hai Phong Pharmaceutical JSC's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Hai Phong Pharmaceutical JSC's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hai Phong Pharmaceutical JSC's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hai Phong Pharmaceutical JSC's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Hai Phong Pharmaceutical JSC's Debt-to-Asset falls into.



Hai Phong Pharmaceutical JSC Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Hai Phong Pharmaceutical JSC's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Hai Phong Pharmaceutical JSC's Debt-to-Asset for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hai Phong Pharmaceutical JSC  (HSTC:DPH) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Hai Phong Pharmaceutical JSC Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Hai Phong Pharmaceutical JSC's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hai Phong Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 71, Dien Bien Phu, Minh Khai Ward, Hong Bang District, Hai Phong, VNM
Hai Phong Pharmaceutical JSC is engaged in the Manufacture of drugs, pharmaceutical chemicals, and medicinal materials. The company manufactures eye drops, nasal drops, soft gels, and tablets. Its product includes Oxacol Nasal Spray; Haiphaxeda eye drops 5ml; Sedachor Lo 200v; Sedachor and others.

Hai Phong Pharmaceutical JSC Headlines

No Headlines